fluconazole has been researched along with Brain Diseases in 12 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " CsA was immediately stopped, and tacrolimus for prevention of graft-versus-host disease (GVHD) was started on day 2." | 7.71 | Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus. ( Asaka, M; Chiba, K; Hashino, S; Izumiyama, K; Suzuki, S; Takahata, M, 2001) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 5.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| " CsA was immediately stopped, and tacrolimus for prevention of graft-versus-host disease (GVHD) was started on day 2." | 3.71 | Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus. ( Asaka, M; Chiba, K; Hashino, S; Izumiyama, K; Suzuki, S; Takahata, M, 2001) |
| "A 49-year-old man with disseminated histoplasmosis (pulmonary and central nervous system involvement) successfully treated with ketoconazole and fluconazole combination is reported." | 3.70 | [Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection]. ( Astoul, P; Bérard, H; Boutin, C; Cho, K; Cuguillière, A; Frenay, C, 1999) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 1.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binning, MJ | 1 |
| Lee, J | 1 |
| Thorell, EA | 1 |
| Riva-Cambrin, JK | 1 |
| Yasokawa, YT | 1 |
| Yano, H | 1 |
| Murase, S | 1 |
| Shinoda, J | 1 |
| Sakai, N | 1 |
| Singh, S | 1 |
| Singh, P | 1 |
| Sarkar, C | 1 |
| Goel, V | 1 |
| Srivastava, T | 1 |
| Sharma, MC | 1 |
| Behari, M | 1 |
| Kalavsky, E | 1 |
| Kisac, P | 1 |
| Huttova, M | 1 |
| Benca, J | 1 |
| Krcmery, V | 1 |
| Bonifaz, A | 1 |
| Macias, B | 1 |
| Paredes-Farrera, F | 1 |
| Arias, P | 1 |
| Ponce, RM | 1 |
| Araiza, J | 1 |
| Kralovic, SM | 1 |
| Rhodes, JC | 1 |
| Hata, K | 1 |
| Kimura, J | 1 |
| Miki, H | 1 |
| Toyosawa, T | 1 |
| Moriyama, M | 1 |
| Katsu, K | 1 |
| Cunningham, ET | 1 |
| Seiff, SR | 1 |
| Berger, TG | 1 |
| Lizotte, PE | 1 |
| Howes, EL | 1 |
| Horton, JC | 1 |
| Knapp, S | 1 |
| Turnherr, M | 1 |
| Dekan, G | 1 |
| Willinger, B | 1 |
| Stingl, G | 1 |
| Rieger, A | 1 |
| Bérard, H | 1 |
| Astoul, P | 1 |
| Frenay, C | 1 |
| Cuguillière, A | 1 |
| Cho, K | 1 |
| Boutin, C | 1 |
| Takahata, M | 1 |
| Hashino, S | 1 |
| Izumiyama, K | 1 |
| Chiba, K | 1 |
| Suzuki, S | 1 |
| Asaka, M | 1 |
| Troke, PF | 1 |
| Andrews, RJ | 1 |
| Marriott, MS | 1 |
| Richardson, K | 1 |
1 review available for fluconazole and Brain Diseases
| Article | Year |
|---|---|
Phaeohyphomycosis caused by Dactylaria (human dactylariosis): report of a case with review of the literature.
Topics: Amphotericin B; Antifungal Agents; Brain Diseases; Fluconazole; Humans; Immunosuppression Therapy; L | 1995 |
11 other studies available for fluconazole and Brain Diseases
| Article | Year |
|---|---|
Intraventricular fungus ball: a unique manifestation of refractory intracranial candidiasis in an immunocompetent neonate.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Brain Diseases; Candidiasis; Caspofungin; E | 2009 |
[Invasive cerebral aspergillosis in an immunocompetent patient: a case report].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Female; Fluconazole; Humans | 2003 |
Fungal granuloma of the brain caused by Cladosporium bantianum--a case report and review of literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Diseases; Cladosporium; Fluconazole; Granuloma; Head | 2005 |
Neuroinfections and antimicrobials: do we need new molecules or new strategies?
Topics: Anti-Infective Agents; Brain Diseases; Candidiasis; Cross Infection; Drug Resistance, Microbial; Flu | 2007 |
Palatal zygomycosis: experience of 21 cases.
Topics: Absidia; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Child; Diabetic | 2008 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococ | 1996 |
Intraocular coccidioidomycosis diagnosed by skin biopsy.
Topics: Adult; Amphotericin B; Biopsy; Bone Diseases; Brain Diseases; Chorioretinitis; Coccidioidomycosis; D | 1998 |
A case of HIV-associated cerebral histoplasmosis successfully treated with fluconazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Brain Diseases; Central Nervous Sys | 1999 |
[Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection].
Topics: Antifungal Agents; Brain; Brain Diseases; Central Nervous System Fungal Infections; Fluconazole; His | 1999 |
Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus.
Topics: Adult; Anemia, Aplastic; Anticonvulsants; Blood-Brain Barrier; Bone Marrow Transplantation; Brain Di | 2001 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus | 1987 |